Mindray Medical India Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 2.76 Cr
as on 24-10-2024
- Company Age 17 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 10.50%
(FY 2023)
- Profit -58.92%
(FY 2023)
- Ebitda -51.35%
(FY 2023)
- Net Worth 7.98%
(FY 2023)
- Total Assets 229.76%
(FY 2023)
About Mindray Medical India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
Zhang Qiang, Palash Banerjee, and Kewen Xu serve as directors at the Company.
- CIN/LLPIN
U51101MH2007PTC166751
- Company No.
166751
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 2007
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mindray Medical India Pvt. Ltd. offer?
Mindray Medical India Pvt. Ltd. offers a wide range of products and services, including Medical Laboratory Instruments, Biochemistry Analyzer, Surgical & ICU Equipments, Patient Monitoring System, Hematology Analyzers, Patient Monitor Cable Cuff Probe & Sensor, Diagnostic Medical Imaging Equipment, ECG Accessories, IVDs & Analyzers, Hospital & Medical Lights.
Who are the key members and board of directors at Mindray Medical India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Zhang Qiang  | Director | 07-May-2013 | Current |
Palash Banerjee  | Director | 21-Jan-2022 | Current |
| Kewen Xu | Director | 21-Jan-2022 | Current |
Financial Performance and Corporate Structure Insights of Mindray Medical India.
Mindray Medical India Pvt. Ltd., for the financial year ended 2023, experienced significant growth in revenue, with a 10.5% increase. The company also saw a substantial fall in profitability, with a 58.92% decrease in profit. The company's net worth moved up by a moderate rise of 7.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mindray Medical India?
In 2023, Mindray Medical India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mindray Medical India?
Mindray Medical India has a workforce of 182 employees as of Jul 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mindray Medical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mindray Medical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
